Limes Schlosskliniken Valuation Multiples

Limes Schlosskliniken is valued at $178M as of October 2026, a 2.6x revenue multiple. In the last 12 months, Limes Schlosskliniken revenue was $69M and Limes Schlosskliniken EBITDA was $17M.

Limes Schlosskliniken Overview

About Limes Schlosskliniken

Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.


Founded

N/A

HQ

Germany

Employees

200

Financials (LTM)

Revenue: $69M
EBITDA: $17M

EV

$181M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Limes Schlosskliniken Financials

Limes Schlosskliniken reported last 12-month revenue of $69M and EBITDA of $17M.

In the same LTM period, Limes Schlosskliniken generated $17M in EBITDA and $10M in net income.

Revenue (LTM)


Limes Schlosskliniken P&L

In the most recent fiscal year, Limes Schlosskliniken reported revenue of $56M and EBITDA of $14M.

Limes Schlosskliniken is profitable as of last fiscal year, with gross margin of 92%, EBITDA margin of 26%, and net margin of 11%.

See analyst estimates for Limes Schlosskliniken
LTMLast FY202320242025202620272028
Revenue$69M$56M$43M$44M$56M
Gross Profit-$51M$39M$40M$51M
Gross Margin-92%91%92%92%
EBITDA$17M$14M$9M$8M$14M
EBITDA Margin24%26%21%19%26%
EBIT Margin19%19%14%11%19%
Net Profit$10M$6M$4M$4M$6M
Net Margin15%11%9%8%11%
Net Debt-$468K---

Financial data powered by Morningstar, Inc.

Limes Schlosskliniken Stock Performance

Limes Schlosskliniken has current market cap of $178M, and enterprise value of $181M.

Market Cap Evolution


Limes Schlosskliniken's stock price is $599.06.

Limes Schlosskliniken share price decreased by 5.9% in the last 30 days, and increased by 44.5% in the last year.

Limes Schlosskliniken has an EPS (earnings per share) of $21.40.

See more trading valuation data for Limes Schlosskliniken
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$181M$178M-1.9%-5.9%-8.1%44.5%$21.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Limes Schlosskliniken Valuation Multiples

Limes Schlosskliniken trades at 2.6x EV/Revenue multiple, and 10.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Limes Schlosskliniken

EV / Revenue (LTM)


Limes Schlosskliniken Financial Valuation Multiples

As of October 16, 2026, Limes Schlosskliniken has market cap of $178M and EV of $181M.

Limes Schlosskliniken has a P/E ratio of 17.3x.

LTMLast FY202320242025202620272028
EV/Revenue2.6x3.2x4.2x4.2x3.2x
EV/EBITDA10.8x12.6x20.3x22.1x12.6x
EV/EBIT13.9x17.3x31.0x36.3x17.3x
EV/Gross Profit-3.5x4.6x4.5x3.5x
P/E17.3x28.0x45.2x49.4x28.0x
EV/FCF16.8x218.1x(39.4x)74.2x218.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Limes Schlosskliniken Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Limes Schlosskliniken Margins & Growth Rates

Limes Schlosskliniken grew revenue by 28% and EBITDA by 20% in the last fiscal year.

In the most recent fiscal year, Limes Schlosskliniken reported gross margin of 92%, EBITDA margin of 26%, and net margin of 11%.

See estimated margins and future growth rates for Limes Schlosskliniken

Limes Schlosskliniken Margins

Last FY202420252026202720282029
Gross Margin92%92%92%-
EBITDA Margin26%19%26%24%
EBIT Margin19%11%19%19%
Net Margin11%8%11%15%
FCF Margin1%6%1%18%

Limes Schlosskliniken Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth28%1%29%28%
Gross Profit Growth-2%28%-
EBITDA Growth20%(8%)75%20%
EBIT Growth30%(15%)109%30%
Net Profit Growth70%(8%)76%70%
FCF Growth1495%(153%)(66%)1495%

Data powered by FactSet, Inc. and Morningstar, Inc.

Limes Schlosskliniken Operational KPIs

Limes Schlosskliniken's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Limes Schlosskliniken's Rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Limes Schlosskliniken's Rule of X is 93% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Limes Schlosskliniken
LTMLast FY202320242025202620272028
Rule of 4057%52%---
Bessemer Rule of X105%93%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-7%7%8%7%
Opex to Revenue-73%77%81%73%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Limes Schlosskliniken Competitors

Limes Schlosskliniken competitors include Suraksha Diagnostics, Goodwill Pharma, Monash IVF Group, Tınaztepe Sağlık, Shalby, Centrum Medyczne ENEL-MED, Athens Medical Centre, Oncoclínicas, Atrys Health and AirSculpt.

Most Limes Schlosskliniken public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Suraksha Diagnostics$33M$10M5.5x5.0x17.8x15.9x
Goodwill Pharma$70M$18M2.8x-10.5x-
Monash IVF Group$189M$46M1.8x1.7x7.3x8.6x
Tınaztepe Sağlık$69M$21M2.7x-8.7x-
Shalby$119M$17M1.7x1.6x11.8x13.0x
Centrum Medyczne ENEL-MED$219M$28M1.1x-8.4x-
Athens Medical Centre$309M$30M1.1x-10.8x-
Oncoclínicas$1.1B($445M)0.9x0.9x(2.2x)7.0x

This data is available for Pro users. Sign up to see all Limes Schlosskliniken competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Limes Schlosskliniken

Where is Limes Schlosskliniken headquartered?Limes Schlosskliniken is headquartered in Germany.
How many employees does Limes Schlosskliniken have?As of today, Limes Schlosskliniken has over 200 employees.
Is Limes Schlosskliniken publicly listed?Yes, Limes Schlosskliniken is a public company listed on Düsseldorf Stock Exchange.
What is the stock symbol of Limes Schlosskliniken?Limes Schlosskliniken trades under LIK ticker.
When did Limes Schlosskliniken go public?Limes Schlosskliniken went public in 2019.
Who are competitors of Limes Schlosskliniken?Limes Schlosskliniken main competitors include Suraksha Diagnostics, Goodwill Pharma, Monash IVF Group, Tınaztepe Sağlık, Shalby, Centrum Medyczne ENEL-MED, Athens Medical Centre, Oncoclínicas, Atrys Health, AirSculpt.
What is the current market cap of Limes Schlosskliniken?Limes Schlosskliniken's current market cap is $178M.
What is the current revenue of Limes Schlosskliniken?Limes Schlosskliniken's last 12 months revenue is $69M.
What is the current revenue growth of Limes Schlosskliniken?Limes Schlosskliniken revenue growth (NTM/LTM) is 32%.
What is the current EV/Revenue multiple of Limes Schlosskliniken?Current revenue multiple of Limes Schlosskliniken is 2.6x.
What is the current EBITDA of Limes Schlosskliniken?Limes Schlosskliniken's last 12 months EBITDA is $17M.
What is Limes Schlosskliniken's EBITDA margin?Limes Schlosskliniken's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of Limes Schlosskliniken?Current EBITDA multiple of Limes Schlosskliniken is 10.8x.
What is the current FCF of Limes Schlosskliniken?Limes Schlosskliniken's last 12 months FCF is $11M.
What is Limes Schlosskliniken's FCF margin?Limes Schlosskliniken's last 12 months FCF margin is 16%.
What is the current EV/FCF multiple of Limes Schlosskliniken?Current FCF multiple of Limes Schlosskliniken is 16.8x.
How many companies Limes Schlosskliniken has acquired to date?Limes Schlosskliniken hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Limes Schlosskliniken has invested to date?Limes Schlosskliniken hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Limes Schlosskliniken

Lists including Limes Schlosskliniken

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial